JP2019087153A - Medicine management system, medicine management method and medicine management program - Google Patents

Abstract

To simplify management of medicine.SOLUTION: A medicine management system is configured such that an identification information acquisition device for acquiring medicine identification information attached to each medicine and user identification information given to each user and a weighing device for weighing are connected to an information processing device through the network. The information processing device comprises a medicine identification unit for identifying medicine on the basis of the medicine identification information, a use state update unit for updating the use state of the medicine on the basis of the weight of the identified medicine, an abnormality detection unit for detecting occurrence of the abnormality in use of the medicine according to the use state of the medicine, and a screen display control unit for causing a display unit to display a screen which shows the fact that the abnormality is detected if the abnormality is detected.SELECTED DRAWING: Figure 1

Description

  The present invention relates to a medicine management system, a medicine management method, and a medicine management program, and more particularly to management processing of medicine by weighing.

  The dispensing pharmacies and dispensing departments that provide medicines according to the doctor's prescription, and the experimental facilities where academic experiments etc. use medicines, handle a wide variety of medicines. Since the shape of medicines varies widely, such as tablets, powders, granules, and liquids, it has been difficult to grasp how much medicine remains in the past, and in order to optimize medicine inventory, it is necessary to make business more appropriate. Systems have been developed to make them more accurate and efficient.

  In order to grasp the remaining amount of medicine, a technique is known in which the weight of the medicine is measured together with the container by an electronic scale and information on the measurement result is recorded (for example, see Patent Document 1). Patent Document 1 discloses a technique for recording who and when and how much amount of medicine has been put in and out by measuring the objects to be weighed and setting the manner of storage and storage.

  By the way, among the medicines, there are some which are highly toxic, those which have severe side effects, and those which are likely to cause habituation or dependence. These drugs are regulated by the Pharmaceutical Affairs Act and other related laws, and have an obligation to create and keep records on drug inventory and disposal. However, the technology of Patent Document 1 is a technology for managing the amount of medicine used based on the remaining amount of medicine, and the handling of medicine is not considered.

  The present invention has been made to solve such problems, and it is an object of the present invention to simplify drug management.

  In order to solve the above problems, one aspect of the present invention is an identification information acquisition device for acquiring drug identification information attached for each medicine and user identification information given for each user, and a weighing device for weighing a weight A medicine management system configured to be connected to an information processing apparatus via a network, wherein the information processing apparatus includes a medicine identification unit that identifies the medicine based on the medicine identification information, and the medicine identified A usage status update unit that updates the usage status of the medicine based on the weight of the medicine, an abnormality detection unit that detects that an abnormality has occurred in usage of the medicine based on the usage state of the medicine, and the abnormality is detected And a screen display control unit that causes a display unit to display a screen for notifying that the abnormality has been detected.

  According to the present invention, medicine management can be simplified.

FIG. 1 is a diagram showing an operation configuration of a medicine management system according to a first embodiment of the present invention. FIG. 1 is a diagram showing a hardware configuration of an information processing apparatus according to a first embodiment of the present invention. FIG. 1 is a diagram showing a functional configuration of an information processing apparatus according to a first embodiment of the present invention. The figure which shows the structure of the drug information management table which concerns on the 1st Embodiment of this invention. FIG. 6 is a diagram showing the configuration of a user information management table according to the first embodiment of the present invention. The figure which shows the structure of the medicine use condition management table which concerns on the 1st Embodiment of this invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. The flowchart which shows the flow of the process in the medicine management system which concerns on the 1st Embodiment of this invention. The flowchart which shows the flow of the processing which registers medicine in the medicine management system concerning a 1st embodiment of the present invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. The flowchart which shows the flow of the processing which registers a user newly in the medicine management system concerning a 1st embodiment of the present invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. The flowchart which shows the flow of processing of the delivery of the medicine in the medicine management system concerning a 1st embodiment of the present invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. The flowchart which shows the flow of processing of the warehousing of the medicine in the medicine management system concerning a 1st embodiment of the present invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. The flowchart which shows the flow of processing of the warehousing of the medicine in the medicine management system concerning a 1st embodiment of the present invention. The flowchart which shows the flow of the processing which performs the alert display in the medicine management system concerning a 1st embodiment of the present invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. FIG. 6 is a view showing a GUI displayed on the screen of the information processing apparatus according to the first embodiment of the present invention. The figure which shows the condition of use of the medicine concerning a 1st embodiment of the present invention. The relationship figure which shows the relationship between the usage-amount of the chemical | medical agent which concerns on the 1st Embodiment of this invention, and a stock amount. The figure which shows the operation | use form of the medicine management system which concerns on the 2nd Embodiment of this invention. FIG. 7 is a diagram showing a functional configuration of a server and an information processing apparatus according to a second embodiment of the present invention. The figure which shows the structure of the storage place management table which concerns on the 2nd Embodiment of this invention. The figure which shows the aspect of the ordering process which concerns on the 2nd Embodiment of this invention.

First Embodiment
Hereinafter, embodiments of the present invention will be described with reference to the drawings. In this embodiment, a drug management system for weighing the weight of a drug to which drug identification information such as a bar code is given in order to identify the type, and optimizing the stock of the drug based on the measurement result will be described. .

  First, the operation configuration of the medicine management system 1 according to the present embodiment will be described. FIG. 1 is a diagram showing an operation configuration of a medicine management system 1 according to the present embodiment. In a medicine management system 1 according to the present embodiment, an information processing apparatus 4 such as a code reader 2, an electronic scale 3, and a PC (Personal Computer) is connected via a network.

  Furthermore, based on the information received from the information processing device 4, the printer 5 may be included which outputs identification information such as a bar code or a QR code (registered trademark). Further, the information processing apparatus 4 may be configured to transmit an electronic mail via a mail server connectable via a network.

  In the present embodiment, medicine identification information such as a barcode, a QR code, an RFID, an IC tag, or the like is attached in advance to a bottle or package in which the medicine is stored. The drug identification information is information for identifying the name, type, and the like of the drug, and is assigned to each drug when storing the drug. In the case where the medicine is a tablet or the like, the medicine identification information may be attached to a box for collectively storing the medicine.

  In addition, there are various types of medicines such as harmful substances, poisons, medical drugs, first-class medicines, second-class medicines, etc., and regulations for handling each medicine are made. Therefore, there are users who can handle medical drugs and others who can not. So, in this embodiment, user identification information for identifying the handling authority of medicine for every user is given. The user identification information is information attached to a name tag or ID card possessed by the user using a format such as a bar code, a QR code, an RFID, an IC tag or the like.

  The code reader 2 is an identification information acquisition device that reads drug identification information attached to each drug and user identification information assigned to each user, and transmits the read information to the information processing device 4. The code reader 2 may read information of a bar code or a QR code by optical mark recognition, or may be configured to acquire information stored in an RFID or an IC tag.

  The electronic scale 3 is a weighing device that weighs the weight of each bottle or box in which the medicine is stored by a weight sensor and transmits information of the weighed weight to the information processing device 4. In the present embodiment, the electronic scale 3 with a minimum display of 0.01 g is used, but an electronic scale with a minimum display of 0.001 g may be used.

  The printer 5 outputs identification information such as a bar code or a QR code (registered trademark) based on the information received from the information processing device 4. In addition, a reader / writer that rewrites information of an RFID or an IC tag may be used as the printer 5.

  The information processing device 4 identifies the medicine based on the information received from the code reader 2 and the electronic scale 3, and updates the information such as the usage amount of the medicine, the user, and the use date and time based on the information of the identified medicine weight. In the present embodiment, management of medicines is performed by updating information related to information such as the usage amount of the medicine, the user, and the date and time of use in various data tables stored in the information processing device 4.

  Next, the hardware configuration of the information processing apparatus 4 according to the present embodiment will be described with reference to FIG. FIG. 1 is a block diagram showing the hardware configuration of the information processing apparatus 4 according to the present embodiment. The information processing device 4 includes a central processing unit (CPU) 10, a random access memory (RAM) 20, a read only memory (ROM) 30, a hard disk drive (HDD) 40 and an I / F 50. Connected and configured. Further, an LCD (Liquid Crystal Display) 60 which is a display unit and an operation unit 70 such as a keyboard are connected to the I / F 50.

  The CPU 10 is an arithmetic unit and controls the overall operation of the information processing apparatus 4. The RAM 20 is a volatile storage medium capable of high-speed reading and writing of information, and is used as a work area when the CPU 10 processes information. The ROM 30 is a read only non-volatile storage medium, and stores programs such as firmware. The HDD 40 is a non-volatile storage medium capable of reading and writing information, and stores an operating system (OS), various control programs, application programs, and the like.

  The I / F 50 connects and controls the bus 80 and various hardware and networks. The LCD 60 is a visual user interface for the user to confirm the state of the information processing apparatus 4. The operation unit 70 is a user interface, such as a keyboard and a mouse, for the user to input information to the information processing apparatus 4.

  In such a hardware configuration, the software control unit is configured by the CPU 10 performing operations according to the steps of the program stored in the ROM 30 and the steps of the program loaded to the RAM 20 from the storage medium such as the HDD 40 or the optical disk. Ru. The combination of the software control unit configured in this manner and hardware configures a functional block that realizes the function of the information processing device 4 according to the present embodiment, and realizes a medicine management method and a medicine management program. .

  Next, the functional configuration of the information processing apparatus 4 according to the present embodiment will be described with reference to FIG. As shown in FIG. 3A, the information processing apparatus 4 according to the present embodiment includes a communication control unit 410, a medicine information control unit 420, a user information control unit 430, a usage status updating unit 440, a condition setting unit 450, It includes an abnormality detection unit 460, an identification information generation unit 470, a storage unit 480, and a screen display control unit 490.

  The communication control unit 410 receives information output from the code reader 2 or the electronic scale 3 and transmits / receives electronic mail via the network to which the information processing apparatus 4 is connected. As shown in FIG. 3B, the drug information control unit 420 identifies drug information stored in the drug identification unit 421 for identifying a drug based on drug identification information and the drug information management table 110 as drug identification information. And a drug information updating unit 422 that updates based on the Further, the medicine information control unit 420 creates an e-mail including medicine identification information of the medicine identified by the medicine identification unit 421.

  As shown in FIG. 3C, the user information control unit 430 includes a user identification unit 431 for identifying the user based on the user identification information, and stores the user information in the user information management table 120 described later. A user information updating unit 432 is provided to update the information of the user being used based on the user identification information.

  The use status update unit 440 updates the drug use status management table 130 that manages the use status for each drug based on the information stored in the drug information management table 110 and the user information management table 120.

  The condition setting unit 450 sets various conditions based on the items input by the user of the medicine management system 1 operating the information processing device 4. For example, when it is desired to grasp the use condition of medicine for three months, the user of medicine management system 1 operates the information processing apparatus 4 to obtain the condition of acquiring the use condition of “drug P” for “three months”. It is possible to set and obtain information on the usage status of "Drug P" for "3 months".

  The condition designated by the user is used by the condition setting unit 450 to acquire information on the usage state of the drug arbitrarily designated by the user of the drug management system 1 and to detect an abnormality in the usage state of the drug. .

  The abnormality detection unit 460 detects, based on the medicine use status management table 130, whether or not an abnormality in the use of medicine has occurred. Further, the abnormality detection unit 460 detects an abnormality based on the user identification information and the medicine identification information, when the user tries to handle the medicine for which the usage right is not used. Further, the abnormality detection unit 460 detects an abnormality in the use of the medicine based on the condition designated by the user of the medicine management system 1 and the medicine use status management table 130.

  The identification information generation unit 470 executes generation of a barcode or QR code or rewriting of an RFID or IC tag as user recognition information for recognizing a new user or medicine recognition information for recognizing a new medicine. Do.

  The storage unit 480 is a storage area in which the medicine information management table 110, the user information management table 120, and the medicine use status management table 130 are stored. The screen display control unit 490 controls a GUI (Graphical User Interface) and the like displayed on the LCD 60.

  Next, respective information configurations of the medicine information management table 110, the user information management table 120, and the medicine use status management table 130 stored in the storage unit 480 will be described with reference to FIGS. 4 to 6. FIG.

  FIG. 4 is a medicine information management table 110 according to the present embodiment. The drug information management table 110, as shown in FIG. 4, includes “drug ID”, “drug name”, “registration date”, “expiration date”, “total weight”, “content”, “handling” as drug information. It is a data table configured to include information of “information” and “media code”.

  The drug ID is information for identifying a drug indicated by drug identification information, and is provided for each drug. The drug name is information on the drug name. In the case where medicines of the same type have different contents or packaging modes, the medicine ID and the medicine name are distinguished and stored in the medicine information management table 110. The registration date is information indicating the date when the drug information is registered in the drug information management table 110.

  The expiration date is information indicating the expiration date of the medicine. The total weight is information on the weight of the drug including the package at the time of storage. The content is information indicating the content of the drug described in the package or instruction of the drug. The handling information is information indicating the classification of medicines, for example, poisonous medicines, medicines for medical treatment, etc., for which medicines are regulated. In addition, each medicine may include information indicating a place where the medicine is stored, a key, and the like.

  Medicode is a 5-digit alphanumeric identification information defined for each drug, and is commonly used as a standard code for medical drugs at medical institutions. Therefore, since the same Medicode is predetermined for the same drug, the Medicode can recognize the drug. In the present embodiment, the medicine code is input on the medicine information input screen 1010. The specific configuration of the medicine information input screen 1010 will be described later.

  FIG. 5 is a user information management table 120 according to the present embodiment. As shown in FIG. 5, the user information management table 120 is a data table configured to include, as user information, information on each of “user ID”, “handling authority”, and “ordering authority”.

  The user ID is information for identifying a person registered as a user of the medicine management system 1 indicated by the user identification information. The handling authority is information indicating to which medicine the authority to handle the medicine is given for each type of medicine, and the ordering authority indicates whether the authority to order the medicine is given for each type of medicine It is information to show. The handling authority and the ordering authority are set when the user information is registered in the user information management table 120. The process of registering user information in the user information management table 120 will be described later.

  FIG. 6 is a medicine use condition management table 130 according to the present embodiment. The drug use status management table 130 is a data table managed for each drug ID, and as information on the drug use status, “delivery date / time”, “delivery weight”, “receipt date / time”, “warehousing weight”, It is a data table comprised including each information of "user ID."

  The leaving date is information indicating the leaving date of the medicine. The delivery weight is information indicating the weight of the medicine measured at the time of delivery. The receipt date is information indicating the receipt date of the medicine. The storage weight is information indicating the weight of the medicine measured at the time of storage. The user ID is used to indicate the user who made the goods in and out of the medicine.

  With such a configuration, the medicine management system 1 according to the present embodiment measures the weight of the medicine to which the medicine identification information is given, and manages the medicine inventory based on the measurement result.

  Next, the flow of processing in the medicine management system 1 according to the present embodiment will be described. In the present embodiment, as shown in FIG. 7, by operating the code reader 2 and the electronic scale 3 in accordance with the GUI displayed on the screen of the information processing device 4, medicine identification information and medicine weight information are acquired.

  First, the flow of processing immediately after activating the medicine management system 1 according to the present embodiment will be described. FIG. 7 shows a GUI of the medicine management system 1 according to the present embodiment. In FIG. 7 and FIG. 8, the flow of processing from the start screen of the medicine management system 1 to the management menu will be described.

  When the medicine management system 1 is activated in the information processing device 4, the screen display control unit 490 causes the LCD 60 to display the start screen 701 of the medicine management system 1 (S801). The start screen 701 displays a dialog 702 prompting the user of the medicine management system 1 to cause the code reader 2 to authenticate the identification card or the like to which the user authentication information is attached.

  When the user authentication information is recognized by the code reader 2 while the start screen 701 is displayed, the communication control unit 410 acquires user recognition information from the code reader 2 and the user information control unit 430 And identify the user based on the acquired user recognition information (S802). In the following description, unless otherwise specified, the handling authority is “1XXXX”, the user ID is “0001”, and a user who is given an ordering authority is taken as an example.

  The screen display control unit 490 acquires the information of the user A identified in S802 from the user information management table 120, and causes the LCD 60 to display a screen corresponding to the acquired user identification information of the user A (S803). . Therefore, in S803, the operation menu 703 is displayed, which allows the user to place an order, for which the handling authority is "1 X XXX".

  The business menu 703 is displayed including the control key 704, the goods issue key 705, the storage key 706, the stock / inventory key 707, and the order status key 708. The management key 704 is operated to manage medicines in the medicine management system 1, and is displayed when the user's handling authority is "1XXXX".

  The delivery key 705 is operated to issue a medicine managed by the medicine management system 1, and is displayed regardless of the user's handling authority. The storage key 706 is operated to store the medicine managed by the medicine management system 1, and is displayed regardless of the user's handling authority.

  The inventory / inventory key 707 is operated to perform inventory confirmation and inventory of medicines managed by the medicine management system 1, and is displayed when the user's handling authority is "1XXXX". When the inventory / inventory key 707 is operated, the medicine information control unit 420 causes the LCD 60 to display a list of medicines managed by the medicine management system 1 via the screen display control unit 490. The display mode of the list of medicines will be described later. The order status key 708 is operated to order a drug managed by the drug management system 1, and is displayed when the user is given the ordering authority.

  When the management key 704 is operated, the screen display control unit 490 changes the screen from the task menu 703 to the management menu 7041. The management menu 7041 is displayed including a registration key 7042, a discard key 7043, a usage status key 7044, and a user registration key 7045.

  The registration key 7042 is operated to register a drug managed by the drug management system 1. The discard key 7043 is operated to discard the medicine managed by the medicine management system 1. The usage status key 7044 is operated to confirm the usage status of the drug managed by the drug management system 1. The user registration key 7045 is operated to newly register the user of the medicine management system 1.

  Thus, in the medicine management system 1 according to the present embodiment, the display mode of the work menu 703 differs depending on the user. Therefore, for example, since it is possible to limit the user who can place an order for medicine and to limit the registration of a new user, it is possible to provide the medicine management system 1 in accordance with the work performed by the user.

  Next, the flow of processing for registering a drug in the drug management system 1 according to the present embodiment will be described. When registering medicines in the medicine management system 1, it is necessary to operate the registration key 7042 displayed on the management menu 7041. Therefore, it is possible to register a medicine managed by the medicine management system 1 only when the handling authority of the user is "1XXXX".

  When the registration key 7042 is operated, the screen display control unit 490 causes the management menu 7041 to transition to the medicine registration screen 7046. The user operates either the continuous registration key 7047 or the new registration key 7048 displayed on the drug registration screen 7046 to register a drug managed by the drug management system 1.

  FIG. 9 is a flow chart showing the flow of processing for registering a drug in the drug management system 1 according to the present embodiment. The screen display control unit 490 determines whether to newly register a medicine in the medicine management system 1 based on the operation of the continuous registration key 7047 or the new registration key 7048 in the medicine registration screen 7046 (S901) .

  The user operates the continuous registration key 7047 when registering a drug already managed by the drug management system 1 and newly registers it when registering a new drug managed by the drug management system 1. Operate the key 7048.

  When the new registration key 7048 is operated, the screen display control unit 490 determines that the medicine is newly registered in the medicine management system 1 (S901 / YES), and displays the screen 1000 shown in FIG. On the screen 1000, a dialog 1001 for prompting the user to input information on a newly registered medicine is displayed.

When the dialog 1001 is operated, the screen display control unit 490 causes the medicine information input screen 1010 to be displayed (S902). On the drug information input screen 1010, “drug ID”, “drug name”, “content”, “handling information”, “shape of drug”, “medic code”, “expiration date”, “packed number”, etc. Items for entering are displayed. At this time, as for the “drug ID”, those not registered in the drug information management table 110 are displayed.

  The user can select items such as "Drug Name", "Contents", "Handling Information", "Medicine Shape", "Medi Code", "Expiration Date", "Packaging Count", ie, "Drug ID" For items other than the above, enter the information on the drug to be newly registered, and when the entry is completed, operate the OK key 1011. As for "Medicode", there are medicines that are not defined, so "Medicode" is not mandatory. Also, for example, for liquid medicine, since the medicine management system 1 manages in a state where the bottle is filled with the medicine, the input of “the number of packages contained” is not essential.

  When the OK key 1011 is operated, the drug information control unit 420 selects the "drug ID", "drug name", "content", "handling information", "drug shape", "media code", etc. at that time. The values entered in the items such as "expiration date for consumption" and "number of packages inserted" are written in the medicine information management table 110, and medicine information is registered (S903). When the drug information is registered by the drug information control unit 420, the screen display control unit 490 causes the screen 1200 to be displayed (S906).

  When the continuous registration key 7047 is operated, the screen display control unit 490 determines that the medicine management system 1 does not newly register a medicine (S901 / NO), and displays the screen 1100 (S904). The screen 1100 displays a dialog 1101 prompting the user to read the drug identification information attached to the drug.

  The user causes the code reader 2 to recognize the drug identification information attached to the drug in accordance with the dialog 1101. The drug recognition information recognized by the code reader 2 is transmitted to the information processing device 4. The drug information control unit 420 performs authentication in the drug management system 1 for the drug of “drug ID” corresponding to the received drug recognition information (S905).

  In the process of S 905, an item for inputting “expiration date of consumption” is displayed on the screen 1110 after authentication of medicine. When the “expiration date” of the medicine authenticated in S 905 is input, the medicine information control unit 420 causes the “expiration time” to be input in the medicine information corresponding to the “medicine ID” of the authenticated medicine. Update drug information. When the medicine information is updated, the screen display control unit 490 causes the screen 1200 to be displayed (S906).

  As described above, the processes of S904 and S905 are processes for continuously registering the medicine having the same package and content. Therefore, when the medicine management system 1 manages medicines of the same package and content, the "drug name", "content", "handling information", "expiration date", "Medicode", "packaging" Since it is not necessary for the user to input "number of items," management of medicine can be simplified.

  Also, some medicines may not be used in a specific season. With regard to such medicines, after performing disposal processing, the medicine information on the medicines is left in the medicine information management table 110, and the management in the medicine management system 1 is resumed for the same package and contents. In the case, the processing of S904 and S905 may be performed. Details of the disposal of the medicine will be described later.

  The screen 1200 displays a dialog 1201 prompting to weigh the weight of the medicine. The user uses the electronic balance 3 to weigh the medicine according to the dialog 1201. The electronic balance 3 transmits the information on the weight of the measured medicine to the information processing device 4. The screen display control unit 490 causes the screen 1200 to display the weight of the received medicine and the OK key 1203.

  At this time, the display mode of the dialog 1201 may be changed so that the weight of the medicine received from the electronic balance 3 is displayed in the dialog 1201. When the OK key 1203 is operated, the medicine information control unit 420 writes information of “total weight” of the medicine in the medicine information management table 110 based on the received information of the medicine weight (S 907).

  When the information of “total weight” is written in the medicine information management table 110, the screen display control unit 490 causes the screen 1210 to be displayed (S908). A dialog 1211 and an OK key 1212 are displayed on the screen 1210 to notify that the drug registration process is completed. When the OK key 1212 is operated, the drug information control unit 420 ends the process. The screen display control unit 490 causes the task menu 703 to be displayed again.

  The screen display control unit 490 does not perform any operation on the keys displayed on the business menu 703 during a predetermined time (for example, three minutes) after the business menu 703 is displayed. In this case, the start screen 701 may be displayed again.

  Next, a flow of processing in which the user A registers a new user B in the medicine management system 1 according to the present embodiment will be described. In the medicine management system 1 according to the present embodiment, if the handling authority of the user A managed by the user information management table 120 is not “1XXXX (X: arbitrary value)”, a new medicine management system 1 is used. User B can not be registered.

  The display mode of the business menu 703 displayed after authentication of the user identification information differs depending on the handling authority of the user, and the user registration key 7045 is displayed only when the handling authority of the user is "1 X XXX". It is The following description is given on the assumption that the handling authority of the user A is "1 X XXX".

  FIG. 13 is a flowchart showing a flow of processing for registering a new user B in the medicine management system 1 according to the present embodiment. In the task menu 703, when the user registration key 7045 is operated (S1301), the screen display control unit 490 causes the LCD 60 to display the user registration screen 1400 (S1302).

  With respect to the item 1401 for setting the handling authority of the user (hereinafter referred to as “user B”) who newly registers in the medicine management system 1 and the item 1402 for setting ordering authority for the user A. Enter the settings. In the example shown in FIG. 14, “management permission”, “toxic substance key”, “pharmaceutical drug key”, “type 1 drug key”, “type 2 drug key”, etc. for the handling authority There is an item.

  The user A operates the key displayed in the item 1401 according to the handling authority given to the user B. Then, the user information control unit 430 registers the user information in the user information management table 120 based on the operation performed on the key displayed in the item 1401 (S1303).

  For example, when an operation for which the handling authority is permitted is performed for the item 1401, the user information control unit 430 sets “1”, and an operation for not permitting the handling authority is performed for the item 1401. In the case, the user information control unit 430 sets “0”.

  That is, in the item 1401, the user information of the user B is operated by the “management permission”, the “toxic substance key”, the “pharmaceutical drug key”, the “first class drug key”, and the “second class drug key” And the user B in the user information management table 120 is authorized to handle “management permission”, “toxic substance”, “pharmaceutical pharmaceuticals”, “first kind pharmaceuticals”, “second kind pharmaceuticals” The handling authority of is registered as "11111".

  In addition, when only the "Type 2 drug key" is operated and only the handling authority for the "type 2 drug" is granted, the user information control unit 430 registers the handling authority of the user B as "00001". Do. The display mode of the key of the item 1401 may be changed according to the classification of the medicine managed in the medicine management system 1. For example, a key may be displayed to set the handling authority for the bio-based pharmaceutical.

  When the user information of the user B is registered in the user information management table 120, the screen display control unit 490 causes the OK key 1403 to be displayed on the user registration screen 1400, and when the OK key 1403 is operated, use is made. The personal information control unit 430 ends this processing, and the screen display control unit 490 displays a screen notifying that user registration has been completed (S1304).

  As described above, in the medicine management system 1 according to the present embodiment, only the user having the right to perform new user registration can execute the user registration. It is possible to simplify the business operation of permitting use only to certain users.

  Next, the flow of the process of taking out the medicine in the medicine management system 1 according to the present embodiment will be described. FIG. 16 is a flow chart showing the flow of processing for taking out a medicine in the medicine management system 1 according to the present embodiment.

  The user authenticates the user identification information in the medicine management system 1 as described in FIG. The screen display control unit 490 causes the LCD 60 to display the task menu 1500 shown in FIG. 15 based on the “handling authority” corresponding to the “user ID” of the authenticated user identification information.

  When the delivery key 1501 included in the operation menu 1500 is operated, the screen display control unit 490 causes the LCD 60 to display a screen 1510 including a dialog 1511 prompting reading of the drug identification information attached to the drug (S1601) . The user causes the code reader 2 to recognize the drug identification information attached to the drug in accordance with the dialog 1511.

  The drug recognition information recognized by the code reader 2 is transmitted to the information processing device 4. The drug information control unit 420 performs authentication in the drug management system 1 for the drug of "drug ID" corresponding to the received drug recognition information (S1602).

  Once the medicine has been authenticated, the screen display control unit 490 displays a screen 1520 including a dialog 1521 prompting the weighing of the medicine on the LCD 60 (delivery clock amount screen display, S1603). The user uses the electronic balance 3 to weigh the medicine according to the dialog 1521. The electronic balance 3 transmits the information on the weight of the measured medicine to the information processing device 4 (S1604).

  The screen display control unit 490 causes the screen 1520 to display the weight of the received medicine and the OK key 1522. At this time, the display mode of the dialog 1521 may be changed so that the weight of the medicine received from the electronic balance 3 is displayed on the dialog 1521.

  When the OK key 1522 is operated, the medicine information control unit 420 causes the medicine use status management table 130 to “delivery date and time” of the medicine, and “delivery weight”, based on the received medicine weight information, The information of "user ID" is written, and the medicine use status management table 130 is updated (S1605). When the medicine use status management table 130 is updated, the screen display control unit 490 displays on the LCD 60 a screen 1530 notifying that the delivery has been completed.

  When the inventory / inventory key 707 is operated, the medicine information control unit 420 displays a list of medicines managed by the medicine management system 1 based on the medicine use status management table 130 via the screen display control unit 490. Display on the LCD 60. At this time, the drug information control unit 420 sets “Drug ID”, “remaining amount”, “handling information”, “consumption” for each drug as “(total weight) − (weight at storage) =“ remaining amount ”). “Time limit” and the like are displayed on the LCD 60 as a list of medicines.

  Next, the flow of the process of storing the medicine in the medicine management system 1 according to the present embodiment will be described. FIG. 18 is a flowchart showing the flow of the process of storing the medicine in the medicine management system 1 according to the present embodiment.

  The user authenticates the user identification information in the medicine management system 1 as described in FIG. The screen display control unit 490 causes the LCD 60 to display the task menu 1700 shown in FIG. 17 based on the “handling authority” corresponding to the “user ID” of the authenticated user identification information.

  When the storage key 1701 included in the operation menu 1700 is operated, the screen display control unit 490 causes the LCD 60 to display a screen 1710 including a dialog 1711 prompting reading of drug identification information attached to a drug (S1801). .

  The user causes the code reader 2 to recognize the drug identification information attached to the drug in accordance with the dialog 1711. The drug recognition information recognized by the code reader 2 is transmitted to the information processing device 4. The drug information control unit 420 performs authentication in the drug management system 1 for the drug of “drug ID” corresponding to the received drug recognition information (S1802).

  When the medicine is authenticated, the screen display control unit 490 displays the screen 1720 including the dialog 1721 prompting the weighing of the medicine on the LCD 60 (storage clock amount screen display, S1803). The user uses the electronic balance 3 to measure the weight of the medicine according to the dialog 1721. The electronic scale 3 transmits the information on the weight of the measured medicine to the information processing device 4 (S1804).

  The screen display control unit 490 causes the screen 1720 to display the weight of the received medicine and the OK key 1722. At this time, the display mode of the dialog 1721 may be changed so that the weight of the medicine received from the electronic balance 3 is displayed in the dialog 1721.

  When the OK key 1722 is operated, the medicine information control unit 420 causes the medicine use status management table 130 to “receive time and date of receipt of the medicine” and “weight at receipt time”, based on the received information on the weight of the medicine, The information of "user ID" is written, and the medicine use status management table 130 is updated (S1805). When the medicine use status management table 130 is updated, the screen display control unit 490 displays on the LCD 60 a screen 1730 notifying that the storage is completed.

  In addition, based on the information on the “date of receipt” and the “expiration date” of the medicine corresponding to the medicine ID authenticated in S1802, for example, when the “expiration date” is less than 18 months, the medicine information control unit 420 A dialog prompting the disposal of the medicine may be displayed on the LCD 60. The medicine information control unit 420 may cause the LCD 60 to display a dialog prompting the user to discard the medicine whose medicine has a predetermined amount (for example, less than 5%).

  Next, the flow of processing for discarding the medicine in the medicine management system 1 according to the present embodiment will be described. FIG. 20 is a flowchart showing a flow of processing for discarding the medicine in the medicine management system 1 according to the present embodiment.

  The user authenticates the user identification information in the medicine management system 1 as described in FIG. The screen display control unit 490 causes the LCD 60 to display the task menu 1900 shown in FIG. 19 based on the “handling authority” corresponding to the “user ID” of the authenticated user identification information.

  When the management key 1901 of the task menu 1900 is operated, the screen display control unit 490 displays the management menu 1910 on the LCD 60. When the discard key 1911 included in the management menu 1910 is operated (S2001), the screen display control unit 490 causes the LCD 60 to display a screen 1920 including a dialog 1921 prompting reading of the drug identification information attached to the drug. (S2002).

  The user causes the code reader 2 to recognize the drug identification information attached to the drug in accordance with the dialog 1921. The drug recognition information recognized by the code reader 2 is transmitted to the information processing device 4. The drug information control unit 420 performs authentication in the drug management system 1 for the drug of “drug ID” corresponding to the received drug recognition information (S2003).

  When the medicine is authenticated, the screen display control unit 490 displays a screen 1930 including a dialog 1931 prompting the weighing of the medicine on the LCD 60 (discarded clock amount screen display, S2004). The user weighs the medicine using the electronic balance 3 according to the dialog 1931. The electronic balance 3 transmits information on the weight of the measured medicine to the information processing device 4 (S2005).

  The screen display control unit 490 causes the screen 1930 to display the weight of the received medicine and the OK key 1932. At this time, the display mode of the dialog 1931 may be changed so that the weight of the medicine received from the electronic balance 3 is displayed in the dialog 1931.

  When the OK key 1932 is operated, the medicine information control unit 420 causes the medicine usage status management table 130 to “discard date and time” of the medicine based on the received medicine weight information, and “waste weight”, The information of "user ID" is written, and the drug use status management table 130 is updated (S2006). When the medicine use status management table 130 is updated, the screen display control unit 490 displays on the LCD 60 a screen 1940 notifying that the disposal is completed.

  As described above, in the medicine management system 1 according to the present embodiment, the medicine is measured, the weight, the handling date and time, and the history of the medicine user are recorded. Then, based on the recorded information, it is detected whether or not an abnormality has occurred in the usage state of the medicine.

  For example, as shown in the flowchart of FIG. 21, an alert may be displayed when the remaining amount of medicine falls below a predetermined amount. FIG. 21 is a flowchart showing a flow of processing for displaying an alert based on the remaining amount of medicine according to the present embodiment.

  The abnormality detection unit 460 detects, for example, the medicine “xxxxxxxx” based on the information of “contents” of the medicine, “total weight”, and “weight at receipt” among the information registered in the medicine use status management table 130. If ((“total weight” – “weight at storage” / “content”) × 100) ≦ 10 or less (S2101 / YES), it indicates that the remaining amount of the drug “xxxxxxxx” is low The alert display 710 is displayed on the LCD 60 by the screen display control unit 490.

  The screen display control unit 490 causes the alert display 710 to be displayed on the start screen 701 of the medicine management system 1 as shown in FIG. 22. For example, ordering of the medicine for which the alert is displayed is performed or the medicine for which the alert is displayed The alert display 710 is extinguished when the continuous registration is performed, for example.

  The drug identification unit 421 identifies the drug for which the alert display 710 is made based on the drug identification information, and causes the drug information control unit 420 to generate a mail for ordering the identified drug. Then, it may be configured to send an e-mail via the communication control unit 410 and place an order for a drug for which an alert is displayed. At this time, the printer 5 may be configured to output a mail for ordering the medicine identified by the medicine identification unit 421 generated by the medicine information control unit 420.

  As another abnormality detection mode performed by the abnormality detection unit 460, for example, after updating the medicine use condition management table 130 at the time of leaving, the warehousing process is performed even if 24 hours have passed for the medicines of the medicine use condition management table 130 updated. If not, it may be detected that an abnormality has occurred in the handling of the medicine.

  Note that after the drug usage status management table 130 has been updated, if there is no warehousing process within 24 hours after the drug usage status management table 130 has been updated, there is an error in the handling of the drug. The condition of “detecting that it is occurring” is set by the condition setting unit 450 based on the item input by the user operating the information processing apparatus 4.

  Further, the abnormality detection unit 460 may be configured to detect that an abnormality has occurred in the handling of the same medicine when the user at the time of storage and the user at the time of storage are different. In addition, the user operates the information processing apparatus 4 under the condition that “when the user at the time of storage and the user at the time of storage are different for the same medicine, it is detected that an abnormality has occurred in the handling of the medicine”. Are set by the condition setting unit 450 based on the item input. In any case, the screen display control unit 490 displays on the LCD 60 a notification that an abnormality has been detected.

  In addition, in the medicine management system 1 according to the present embodiment, a user who wants to know the use condition of medicine can set conditions and obtain information on the use condition of medicine based on the set conditions. .

  At this time, the user inputs various conditions on the condition setting screen 2300 (FIG. 23) displayed by operating the usage status key 7044 displayed on the management menu 7041. In the condition setting screen 2300, for example, conditions such as “drug name”, “period”, “consumption amount”, “drug classification” can be set. In addition, it is also possible to set conditions of “shape of medicine”, “remaining amount” by providing items for specifying “shape of medicine”, “remaining amount”, etc. on the condition setting screen 2300. . Then, the condition setting unit 450 sets the conditions input on the condition setting screen 2300 and acquires information on the usage status of the medicine.

  For example, in the condition setting screen 2300, it is assumed that a condition for obtaining a drug whose consumption amount is “80% of the internal capacity” and whose expiration date is “within 18 months” is set. At this time, the condition setting unit 450 stores, in the storage unit 480, information on medicines whose “consumption amount” is “80% of the internal capacity” and whose consumption term is “within 18 months”. Acquire based on information in data table. Then, the screen display control unit 490 shows information of medicines whose acquired “consumption amount” is “80% of the internal capacity” and whose expiration date is “within 18 months” in FIG. As a result, the LCD 60 is displayed.

  Further, in the drug information shown in FIG. 24, a check box is provided for each drug name. At this time, for example, when the check box 2400 for specifying the drug "xxxxxxxx" is checked, the condition setting unit 450 manages the relationship between the usage amount of the drug "xxxxxxxx" and the stock amount in the drug use status management table 130. Calculated monthly based on the information of the medicine "xxxxxxxx" being used.

  Then, the screen display control unit 490 causes the LCD 60 to display a relationship diagram 2500 showing the relationship between the usage amount of the medicine “xxxxxxxx” and the stock amount, as shown in FIG. The relationship diagram 2500 may be displayed on the LCD 60 by providing a soft key for displaying the relationship diagram 2500 on the condition setting screen 2300.

  In FIG. 25, although the inventory amount for each month is displayed as a vertical bar (inventory amounts 2521, 2522, 2253, 2524), and the usage amount for each month is displayed as a line graph (use amount 2510), other display modes It may be By doing this, the user visually determines the usage condition of the medicine, such as in which month the usage amount and the inventory amount increase, by visually observing the relationship diagram 2500 displayed on the LCD 60. Is possible.

Other Embodiments
FIG. 26 is a diagram showing a medicine management system 7 configured by connecting a plurality of medicine management systems 1A, 1B, and 1C via the server 6. The server 6 has a hardware configuration similar to that of the information processing device 4 as described in FIG. 2, and may have a configuration that does not include the LCD 60 and the operation unit 70.

  As shown in FIG. 26, in the medicine management system 1A, a code reader 2A, an electronic balance 3A, and an information processing device 4A are respectively configured via a network. In addition, the medicine management system 1A may be configured to include the printer 5A. The drug management systems 1B and 1C are also configured in the same manner as the drug management system 1A.

  Each of the information processing devices 4A, 4B, and 4C is connected to the server 6 via a network. In the first embodiment, various processes for managing medicines have been executed in the information processing apparatus 4, but in the present embodiment, various processes for the server 6 to manage medicines are performed. Run. In the following description, the same parts as those in the first embodiment are denoted by the same reference numerals, and the redundant description will be omitted.

  Next, functional configurations of the server 6 and the information processing devices 4A to 4C according to the present embodiment will be described with reference to FIG. As shown in FIG. 27A, the server 6 includes a communication control unit 410, a medicine information control unit 420, a user information control unit 430, a use status updating unit 440, a condition setting unit 450, an abnormality detection unit 460, and identification information. A generation unit 470 and a storage unit 480 are included. Further, as shown in FIG. 27B, each of the information processing devices 4A, 4B, and 4C includes a communication control unit 411 and a screen display control unit 412.

  The communication control unit 410, medicine information control unit 420, user information control unit 430, usage status update unit 440, condition setting unit 450, abnormality detection unit 460, identification information generation unit 470, storage unit 480, screen display control unit Description of 490 will be omitted, and only differences from the first embodiment will be described. In addition, the communication control unit 411 of each of the information processing devices 4A, 4B, and 4C performs the same process as the communication control unit 410, and the screen display control unit 412 performs the same process as the screen display control unit 490. Do.

  The storage unit 480 of the server 6 includes a storage location management table 140. As shown in FIG. 28, the storage location management table 140 is configured to include “management terminal ID” and “drug ID” respectively assigned to the information processing devices 4A, 4B and 4C. In addition, in order to manage medicines for each medicine classification by the information processing devices 4A, 4B, 4C, it may be configured to include “handling information”.

  That is, when the storage location management table 140 includes the “handling information”, for example, the information processing device 4A manages the second and third kind of medicines, and the information processing device 4C controls the playable object and the first Management of the same kind of medicine.

  Further, in the present embodiment, as shown in FIG. 29A, when the user D of the information processing apparatus 4A does not have the ordering authority when ordering the medicine from the information processing apparatus 4A, the ordering authority is It can be approved by having the user E who has the user operate the information processing apparatus 4C, and can order medicines.

  In the example shown in FIG. 29, when the user D who does not have the ordering authority uses the ordering from the information processing device 4A, the ordering authority is given to any one of the information processing devices 4B and 4C connected to the server 6. With the approval of the owning user (here, the user E has the ordering authority), it is possible to place an order.

  Specifically, as shown in the sequence diagram of FIG. 29 (b), when the user D is identified in the information processing apparatus 4A, an operation for the user D to place an order for medicine (ordering operation , S2901), the medicine information control unit 420 approves that the user D orders the medicine from the information processing apparatus 4A to the information processing apparatus 4C in which the user E having the ordering authority is identified. Information (order placement screen display information transmission, S2902) for displaying a screen for ordering (order placement screen) is transmitted.

  When the screen display control unit 412 of the information processing device 4C receives the ordering screen display information 2902, the screen display control unit 412 causes the LCD 60 to display an ordering screen. Then, when an operation (approval operation, S2903) for approving placing an order for a medicine is performed on the ordering screen displayed on the LCD 60 of the information processing apparatus 4C, the medicine information control unit 420 executes the information processing apparatus 4A. Then, the information processing apparatus 4A transmits information (approval screen display information transmission, S2904) for displaying a screen (approval screen) indicating that the user D is approved to place an order for a medicine.

  In addition, when the approval operation 2903 is executed, the medicine information control unit 420 creates an e-mail including identification information of the medicine designated by the user D in the order placement operation 2901 and makes the created e-mail through the network. Send to the drug wholesaler and complete this process.

  When the screen display control unit 412 of the information processing device 4A receives the approval screen display information 2904, the screen display control portion 412 causes the LCD 60 of the information processing device 4A to display the approval screen. When the approval screen is clicked, the screen display control unit 412 of the information processing device 4A displays the task menu 703.

  As described above, in the present embodiment, in response to an order request from an information processing apparatus in which a user without order permission is identified, from another information processing apparatus in which a user with order permission is identified. By approving the order request, it is possible to place an order for the drug. Therefore, since the user who does not have the ordering authority can not order the medicine, the management of the medicine according to the authority of the user can be simplified.

DESCRIPTION OF SYMBOLS 1 medicine management system 2 code reader 3 electronic balance 4 information processor 5 printer 110 medicine information management table 120 user information management table 130 medicine use condition management table 410 communication control part 420 medicine information control part 430 user information control part 440 use Condition update unit 450 Condition setting unit 460 Abnormality detection unit 470 Identification information generation unit 480 Storage unit 490 Screen display control unit

JP 2000-198507 A

Claims (6)

An identification information acquisition device for acquiring drug identification information attached for each medicine and user identification information given for each user, and a weighing device for weighing a weight are connected to an information processing device via a network A drug management system,
The information processing apparatus is
A medicine identification unit for identifying the medicine based on the medicine identification information;
A use status update unit updating the use status of the medicine based on the weight of the medicine identified;
An abnormality detection unit that detects that an abnormality has occurred in the use of the medicine based on the use state of the medicine;
A screen display control unit for displaying a screen notifying that the abnormality is detected on the display unit when the abnormality is detected;
Pharmaceutical management system characterized by including. The abnormality detection unit
The medicine management system according to claim 1, wherein the abnormality is detected based on a predetermined condition set by operating the information processing apparatus and a use state of the medicine. The abnormality detection unit
The medicine management system according to claim 1 or 2, wherein the abnormality is detected based on the identified weight of the medicine and the use condition of the medicine. The information processing apparatus is
A user identification unit that identifies the user based on the user identification information;
The abnormality detection unit
The medicine management system according to claim 1, wherein the abnormality is detected when the user identification information of the identified user does not have an authority to handle the medicine. An identification information acquisition device for acquiring drug identification information attached for each medicine and user identification information given for each user, and a weighing device for weighing a weight are connected to an information processing device via a network A drug management method in the system,
Identifying the drug based on the drug identification information;
Update the usage status of the drug based on the identified weight of the drug,
A medicine management method comprising displaying on the display unit a screen notifying that the abnormality has been detected when it is detected that an abnormality has occurred in the use of the medicine based on the usage condition of the medicine. . An identification information acquisition device for acquiring drug identification information attached for each medicine and user identification information given for each user, and a weighing device for weighing a weight are connected to an information processing device via a network Drug management program in the system,
Identifying the drug based on the drug identification information;
Updating the usage of the drug based on the identified weight of the drug;
Detecting that an abnormality has occurred in the use of the medicine based on the use condition of the medicine;
Displaying on the display unit a screen notifying that the abnormality is detected when the abnormality is detected;
A medicine management program characterized by causing a computer to execute.